Sphera Biotech US Fund, L.P. is a hedge fund based in Tel Aviv, Israel. According to its most recent Form D, filed Apr 27, 2026, the fund has sold $32,071,088 of interests to 11 investors since its first sale in Oct 2018. The minimum investment it accepts from an outside investor is $500,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Doron Breen; Nir Arkin; Adi Hanetz.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $32,071,088Cumulative sales reported on Form D
- Investors
- 11
- First sale
- Oct 1, 2018
- Minimum investment
- $500,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Doron Breen; Nir Arkin; Adi Hanetz
- Latest Form D
- Apr 27, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures
Size compared with every hedge fund
Raised more than 77% of the 13 hedge funds based in Israel, and more than 37% of all 10,157 that report sales.